Articles related to Pain Medicine

The FDA notice added that a letter was sent out about the recall. However, it did not include a press release or other specific details.

“The key word is association. This study does not establish causality. For absolute, catastrophic harm to an appropriately selected, monitored pain patient, the risk is small.” – Sean Mackey, MD, PhD, Chief of the Division of Stanford Pain Medicine

“The more frequently the brain is exposed to migraine attacks, the more likely it is to become sensitized…early intervention is critical.” – Dr. Andrew Blumenfeld, Director of the San Diego Headache Center and The Los Angeles Headache Center San Diego/Los Angeles.

“Patients and doctors [lack] enough research to inform medical guidelines and many patients are using these products without talking to their doctor about them.” —Senior White House official

“The pain may not correlate with the extent of the disease. A patient with severe endometriosis may report little pain while someone with little extent of disease may report much pain.”

Less than half of people prescribed gabapentin will not notice meaningful pain relief but will likely experience side effects or adverse events.